21st CEO Survey: key findings from the pharmaceutical and life sciences industry
Preparing for disruption
Pharmaceuticals and life sciences
In a world facing enormous health challenges and an industry undergoing profound disruption, we are actively helping businesses, governments and individuals through the transition to a new health economy. PwC’s purpose is "to build trust in society and solve important problems". Our Team at PwC demonstrate a commitment and passion to this purpose every day in the work we deliver for and with the health industries.
How can we help
PwC has a strong Pharma team with relevant knowledge and experience in China to provide our clients with practical solutions. Our approach is to bring clients a multidisciplinary set of capabilities tailored to their unique business needs. These capabilities permit us to leverage deep resources and experience across our practice in pharmaceutical industry. Our Assurance and Tax practices provide unique financial, regulatory and compliance skill sets; our Consulting Services cover the full spectrum of strategic planning and operational concerns; and our Deals Services help clients through each stage of the deal process, from M&A strategy to post-acquisition integration.
Insights
2017 M&A review - pharmaceuticals & medical devices sector
Accounting for options over intellectual property in the pharmaceutical and life sciences industry
A look at current financial reporting issues
2017 H1 M&A review - China pharmaceuticals and medical devices sectors
Drop in value and volume of deals in the M&A market of China pharmaceuticals and medical devices sector.
2016 M&A Review - China pharmaceutical and medical device
M&A in China’s medical device sector.
“New entrants, new health economy” survey findings
New health reform has been rolled out to accommodate the rising of residents income level and healthcare awareness.
20th CEO Survey: Pharmaceuticals & Life Sciences key findings
In this year's survey, 89 pharmaceuticals & life Sciences CEOs from 37 countries share their views on the impact of globalisation, technological change, talent and trust.
Real estate + Healthcare
A new direction for real estate industry transformation
Related content
Contact us
Mark Gilbraith
China & Hong Kong Management Consulting Leader, Health Industries Leader and Consumer & TMT Consulting Leader
Tel: +[86] (21) 2323 2898
Email
Follow us
